Medical-device teams are told automation and traceability are in tension. They are not. Well-designed test automation produces better evidence than manual testing, because every run is recorded the same way. The trick is to build evidence capture into the pipeline rather than bolting it on.

60–80%of regression effort is typically automatable in device software
1 linkfrom requirement to scenario to result to release, maintained automatically
Every runproduces the same structured evidence, reviewable by QA

Automate execution, structure the evidence

Each automated scenario carries its requirement ID. Each run records inputs, outputs, environment and result in a structured format. Review is a step in the pipeline, not a document hunt afterwards.

  • Requirement-tagged scenarios
  • Structured run evidence
  • Review gate before release candidates
  • Traceability report generated, not assembled

Where humans stay essential

Exploratory testing, usability, risk review and release sign-off. Automation gives those people time and better evidence; it does not replace their judgment.

Start with the regression suite

Pick the most repeated manual test set, automate it with evidence capture, and run it on every build for a month. The time saved and the quality of the trail usually make the case for the rest.

Real-world example

Medical-device development team

Before

Manual regression slowed releases; evidence scattered across documents; review painful.

After

Repeatable automated execution with structured evidence and traceable review points. Faster cycles, evidence easy to retrieve.

Key takeaway

Automation and traceability reinforce each other when evidence capture is part of the pipeline. Start with regression, tag everything, review in-line.